(Q40131366)

17 September 2017

1 reference

title

Epstein-Barr virus antigens-a challenge to modern biochemistry (English)

1 reference

17 September 2017

Epstein-Barr Virus Antigens–A Challenge to Modern Biochemistry (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

17 September 2023

0 references

D. A. Thorley-Lawson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289637

17 September 2023

C. M. Edson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289637

17 September 2023

K. Geilinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289637

17 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6289637

17 September 2023

publication date

1 January 1982

1 reference

Advances in Cancer Research

17 September 2017

published in

1 reference

17 September 2017

volume

36

1 reference

17 September 2017

page(s)

295-348

1 reference

Formation of virosomes from influenza subunits and liposomes

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis

17 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination

17 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis

17 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Fatal infectious mononucleosis in a family

17 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Mechanisms of infection with Epstein-Barr virus III. The synthesis of proteins in superinfected Raji cells

17 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

The Regulated Expression of Epstein--Barr Virus. III. Proteins Specified by EBV During the Lytic Cycle

17 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines

17 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

The hr-t Gene of Polyoma Virus

17 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Prevalence of antibody against viruses in the Tiriyo, an isolated Amazon tribe.

17 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate

17 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Detection of virus-specific antigens in EB-(P3HR1) virus-superinfected Raji cells by immunoprecipitation

17 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Isolation of plasma membrane antigens from Epstein-Barr virus-infected lymphoid cells

17 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis

17 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon

17 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus-associated thymidine kinase

17 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Studies on the activity of DNase associated with the replication of the Epstein-Barr virus

17 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma

17 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Deoxyribonuclease activity found in Epstein-Barr virus producing lymphoblastoid cells

17 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

An endonuclease isolated from Epstein-Barr virus-producing human lymphoblastoid cells

17 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Characterization of the Epstein-Barr virion-associated DNA polymerase as isolated from superinfected and drug-stimulated cells

17 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping

17 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).

17 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients

17 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

17 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

A Solid-Phase Radioimmunoassay for Epstein-Barr Virus-Associated Membrane Antigen Prepared From 895-8 Cell Culture Supernatants 2

17 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus

17 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus

17 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates

17 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences

17 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytes

17 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence

17 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells

17 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus

17 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis

17 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Clonal origin for individual Burkitt tumours

17 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma

17 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates

17 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures

17 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography

17 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines

17 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Growth of diploid, epstein-barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions

17 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Infectious mononucleosis: immunoglobulin synthesis by cell lines

17 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA

17 September 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis

17 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma

17 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Two-dimensional Gel Analysis of HSV Type 1-induced Polypeptides and Glycoprotein Processing

17 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Semlike Forest virus membrane proteins. Preparation and characterization of spike complexes soluble in detergent-free medium

17 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Observations on childhood infections with the Epstein-Barr virus

17 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

17 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

17 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells

17 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

17 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antibodies to the R component of Epstein-Barr Virus-Induced Early Antigens in Burkitt's Lymphoma Exceeding in Titer Antibodies to Epstein-Barr Viral Capsid Antigen2

17 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells

17 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

17 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Differential reactivity of human serums with early antigens induced by Epstein-Barr virus

17 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors

17 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

17 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Expression of altered ribonucleotide reductase activity associated with the the replication of the epstein-barr virus

17 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus (EBV) antigenic determinants on subunits of the EBV determined nuclear antigen (EBNA)

17 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

High incidence of Japanese infants with antibody to a herpes-type virus associated with cultured Burkitt lymphoma cells

17 September 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen

17 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex

17 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies

17 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Cytogenetic studies on human lymphoblastoid cell lines from Burkitt's lymphomas and other sources

17 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease

17 September 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes

17 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus antibody levels in children from the West Nile District of Uganda. Report of a field study

17 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n -Butyrate-Treated P3HR-1 Cells

17 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis

17 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus-induced polypeptides: A comparative study with superinfected Raji, IUdR-treated, and n-butyrate-treated P3HR-1 cells

17 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction

17 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx

17 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients

17 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Transformation Induced by Epstein-Barr Virus and the Role of the Nuclear Antigen

17 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus

17 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Tunicamycin — An inhibitor of yeast glycoprotein synthesis

17 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations

17 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Mechanism of infection by Epstein-Barr virus II. Comparison of viral DNA from HR-1 and superinfected raji cells by restriction enzymes

17 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen

17 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells

17 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Chinese journal of otorhinolaryngology

17 September 2023

106

15

71

Li

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level

17 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein

17 September 2023

108

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines

17 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate

17 September 2023

110

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids

17 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen

17 September 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Marker band in one chromosome 14 from Burkitt lymphomas.

17 September 2023

114

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Studies on epstein-barr virus-related antigens. II. Biochemical properties of soluble antigen in raji burkitt lymphoma cells

17 September 2023

115

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Studies on epstein-barr virus-related antigens. III. Purification of the virus-determined nuclear antigen (EBNA) from non-producer raji cells

17 September 2023

116

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

17 September 2023

117

27

2020

Mayyasi

1967

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation

17 September 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

17 September 2023

119

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Establishment of Lines from Normal Human Blood Leukocytes by Co-cultivation with a Leukocyte Line Derived from a Leukemic Child

17 September 2023

120

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses

17 September 2023

121

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Studies of an epstein-barr virus-induced DNA polymerase

17 September 2023

122

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

17 September 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Effective subunit vaccines against an enveloped animal virus

17 September 2023

125

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

17 September 2023

126

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures

17 September 2023

127

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation

17 September 2023

128

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation

17 September 2023

129

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies

17 September 2023

130

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies

17 September 2023

131

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Prevalence, incidence and persistence of EB virus antibody in young adults

17 September 2023

132

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Burkitt's Lymphoma: Its Clinical Course in Relation to Immunologic Reactivities to Epstein-Barr Virus and Tumor-Related Antigens2

17 September 2023

133

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Detection of Epstein-Barr viral genome in nonproductive cells

17 September 2023

134

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics

17 September 2023

135

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides

17 September 2023

136

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Detection of epstein-barr virus early antigen-d and its antibodies by passive hemagglutination

17 September 2023

137

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes

17 September 2023

139

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

17 September 2023

140

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Characterization of an Epstein-Barr virus-induced DNA polymerase

17 September 2023

141

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antibody-Dependent Lymphocyte Cytotoxicity Against Cells Expressing Epstein—Barr Virus Antigens

17 September 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Papain solubilization of the Epstein-Barr virus-induced membrane antigen

17 September 2023

143

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Antibody-dependent cellular cytotoxicity against epstein-barr virus-associated antigens in african patients with nasopharyngeal carcinoma

17 September 2023

145

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma

17 September 2023

146

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Identification of the filtrable leukocyte-transforming factor of qimr-wil cells as herpes-like virus

17 September 2023

147

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Prevalence of antibodies to EB virus and other herpesviruses

17 September 2023

148

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

17 September 2023

149

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus-induced membrane antigens: Immunochemical characterization of triton X-100 solubilized viral membrane antigens from EBV-superinfected raji cells

17 September 2023

150

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Radioimmune precipitation study comparing the epstein-barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA)

17 September 2023

151

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative

17 September 2023

152

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Characterization of lymphoid cell lines established from multiple epstein-barr virus (EBV)-induced lymphomas in a cotton-topped marmoset

17 September 2023

153

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

17 September 2023

154

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies

17 September 2023

155

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures

17 September 2023

156

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins

17 September 2023

157

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis

17 September 2023

158

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus

17 September 2023

159

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Early DNA-binding polypeptides of Epstein-Barr virus

17 September 2023

160

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells

17 September 2023

161

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Appearance of Early and Late Components of Epstein-Barr Virus-Associated Membrane Antigen in Daudi Cells Superinfected with P3HR-1 Virus

17 September 2023

162

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Phosphorylation of polyoma T antigens

17 September 2023

164

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-barr virus-induced transformation of human leukocytes after cell fractionation

17 September 2023

165

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Suppression of glycoprotein formation of Semliki Forest, influenza, and avian sarcoma virus by tunicamycin

17 September 2023

167

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus

17 September 2023

168

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling

17 September 2023

169

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopy

17 September 2023

170

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Formation of protein micelles from amphiphilic membrane proteins

17 September 2023

171

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Changes in the expression of two Epstein-Barr virus-associated antigens, EBNA and RANA, during the cell cycle of transformed human B lymphoblasts

17 September 2023

173

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Protein kinase activity associated with polyoma virus middle T antigen in vitro

17 September 2023

174

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Correlation Between Epstein-Barr Virus Membrane Antigen and Three Large Cell Surface Glycoproteins

17 September 2023

175

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen

17 September 2023

176

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus DNA is amplified in transformed lymphocytes

17 September 2023

179

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid

17 September 2023

180

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis

17 September 2023

181

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis

17 September 2023

184

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells

17 September 2023

185

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

A virus-free immunogen effective against Epstein-Barr virus

17 September 2023

186

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Polypeptides of the Epstein-Barr virus membrane antigen complex

17 September 2023

190

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity

17 September 2023

191

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus

17 September 2023

194

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes

17 September 2023

195

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Biological activity of purified simian virus 40 T antigen proteins

17 September 2023

198

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Development and persistence of immunity to Epstein-Barr virus in man.

17 September 2023

199

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line

17 September 2023

200

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Immunologic Identification of Epstein-Barr Virus Early Antigen in a P3HR-1 Cell Extract2

17 September 2023

201

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion

17 September 2023

202

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Separation of the Complement-Fixing and Early Antigens From Epstein-Barr Soluble Antigen2

17 September 2023

203

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells

17 September 2023

204

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell lines

17 September 2023

205

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established burkitt lymphoma cell lines

17 September 2023

206

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by epstein-barr virus (EBV)

17 September 2023

207

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas

17 September 2023

208

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells

17 September 2023

209

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

17 September 2023

211

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

Persisting oncogenic herpesvirus induced by the tumour promoter TPA

17 September 2023

212

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60428-5

17 September 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6289637

17 September 2023

1 reference